看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | No | Yes |
| Competitors Used |
|---|
| Anuh Pharma Limited |
| Solara Active Pharma Sciences Limited |
| Vasundhara Rasayans Limited |
| Suven Pharmaceuticals Limited |
| Supriya Lifescience Limited |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| 506,260 | 541,540 | 538,634 | 543,064 | 543,434 | 530,549 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | NA | NA | NA | 14% | NA | NA | ||
| Fiscal Year - 1 | 16% | -1% | 23% | 25% | 14% | -2% | ||
| Fiscal Year - 2 | 15% | -4% | 10% | 34% | 34% | 4% | ||
| Fiscal Year - 3 | 16% | 17% | 16% | 36% | 59% | 11% | ||
| Fiscal Year - 4 | 9% | 11% | 19% | 44% | 60% | 12% | ||
| Fiscal Year - 5 | 15% | 7% | 10% | 44% | 53% | 10% | ||
| Average | 14% | 6% | 16% | 33% | 44% | 7% | ||
| Median | 15% | 7% | 16% | 35% | 53% | 10% | ||
| Benchmarks | Ticker | |||||||
| Anuh Pharma Limited | BSE:506260 | |||||||
| Solara Active Pharma Sciences Limited | BSE:541540 | |||||||
| Vasundhara Rasayans Limited | BSE:538634 | |||||||
| Suven Pharmaceuticals Limited | BSE:543064 | |||||||
| Supriya Lifescience Limited | BSE:543434 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | Feb-86 | Sep-82 | Sep-74 | Nov-86 | Nov-87 | Aug-52 | ||
| Latest Fiscal Year | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 6,273 | 13,102 | 374 | 10,485 | 6,706 | 12,488 | ||
| Fiscal Year | 6,470 | 12,889 | 370 | 10,514 | 5,704 | 11,531 | ||
| Fiscal Year - 1 | 5,275 | 14,438 | 379 | 13,403 | 4,609 | 10,517 | ||
| Fiscal Year - 2 | 4,866 | 12,683 | 268 | 13,202 | 5,300 | 11,469 | ||
| Fiscal Year - 3 | 4,320 | 16,169 | 227 | 10,097 | 3,912 | 9,016 | ||
| Fiscal Year - 4 | 3,070 | 13,218 | 213 | 8,338 | 3,200 | 9,082 | ||
| Fiscal Year - 5 | 3,207 | 13,867 | 198 | 9,068 | 2,818 | 7,337 | ||
| Net Income | ||||||||
| Latest Twelve Months | 503 | (2,527) | 60 | 2,792 | 1,745 | 883 | ||
| Fiscal Year | 601 | (5,674) | 59 | 3,003 | 1,191 | 319 | ||
| Fiscal Year - 1 | 362 | (222) | 56 | 4,113 | 899 | (325) | ||
| Fiscal Year - 2 | 306 | (582) | 22 | 4,538 | 1,518 | 607 | ||
| Fiscal Year - 3 | 284 | 2,214 | 29 | 3,623 | 1,236 | 1,478 | ||
| Fiscal Year - 4 | 143 | 1,146 | 30 | 3,170 | 734 | 1,562 | ||
| Fiscal Year - 5 | 234 | 614 | 15 | 2,623 | 394 | 1,123 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | NA | NA | NA | 20,579 | NA | NA | ||
| Latest Fiscal Quarter | NA | NA | NA | NA | NA | NA | ||
| Fiscal Year | 4,457 | 23,510 | 373 | 22,541 | 9,212 | 30,932 | ||
| Fiscal Year - 1 | 4,050 | 28,993 | 345 | 19,657 | 8,203 | 29,039 | ||
| Fiscal Year - 2 | 3,472 | 29,450 | 255 | 18,296 | 7,348 | 28,755 | ||
| Fiscal Year - 3 | 3,326 | 26,136 | 230 | 14,745 | 4,455 | 26,324 | ||
| Fiscal Year - 4 | 3,264 | 21,535 | 247 | 11,728 | 3,364 | 19,892 | ||
| Fiscal Year - 5 | 2,403 | 19,601 | 208 | 7,830 | 2,531 | 16,100 | ||
| Fiscal Year - 6 | 2,092 | 18,215 | 204 | NA | 2,454 | 14,991 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 2,567 | 14,634 | 312 | 19,814 | 7,532 | 17,835 | ||
| Latest Fiscal Quarter | 3,031 | 10,860 | 370 | 19,783 | 9,059 | 23,279 | ||
| Fiscal Year | 2,912 | 9,339 | 319 | 20,507 | 8,154 | 18,087 | ||
| Fiscal Year - 1 | 2,412 | 15,002 | 268 | 17,352 | 6,995 | 17,833 | ||
| Fiscal Year - 2 | 2,138 | 15,249 | 215 | 15,272 | 6,157 | 18,222 | ||
| Fiscal Year - 3 | 1,906 | 15,885 | 199 | 11,808 | 2,686 | 14,787 | ||
| Fiscal Year - 4 | 1,622 | 10,859 | 174 | 8,448 | 1,492 | 13,294 | ||
| Fiscal Year - 5 | 1,646 | 9,559 | 148 | 5,903 | 938 | 11,976 | ||
| Fiscal Year - 6 | 1,496 | 7,640 | 137 | NA | 547 | 10,850 | ||